FOLFIRI-cetuximab
Term · Oncology and biomedicine · MLC-T-ONC-003290
A chemotherapy combination used to treat a certain type of colorectal cancer that has spread to other parts of the body. It includes the drugs leucovorin calcium (folinic acid), fluorouracil, irinotecan hydrochloride, and cetuximab. Also called FOLFIRI-cetuximab regimen.
| Identifier | MLC-T-ONC-003290 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | FOLFIRI-cetuximab regimen |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-003290",
"term": "FOLFIRI-cetuximab",
"field": "Oncology and biomedicine",
"definition": "A chemotherapy combination used to treat a certain type of colorectal cancer that has spread to other parts of the body. It includes the drugs leucovorin calcium (folinic acid), fluorouracil, irinotecan hydrochloride, and cetuximab. Also called FOLFIRI-cetuximab regimen.",
"synonyms": [
"FOLFIRI-cetuximab regimen"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/folfiri-cetuximab/"
}
Record 7,527 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.